>
Switch to:

Cullinan Oncology Quick Ratio

: 39.67 (As of Dec. 2019)
View and export this data going back to 2021. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Cullinan Oncology's quick ratio for the quarter that ended in Dec. 2019 was 39.67.

Cullinan Oncology has a quick ratio of 39.67. It generally indicates good short-term financial strength.

The historical rank and industry rank for Cullinan Oncology's Quick Ratio or its related term are showing as below:


Cullinan Oncology Quick Ratio Historical Data

The historical data trend for Cullinan Oncology's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cullinan Oncology Annual Data
Trend Dec18 Dec19 Dec20
Quick Ratio
25.85 39.67 14.82

Cullinan Oncology Semi-Annual Data
Dec18 Dec19 Dec20
Quick Ratio 25.85 39.67 14.82

Competitive Comparison

For the Biotechnology subindustry, Cullinan Oncology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cullinan Oncology Quick Ratio Distribution

For the Biotechnology industry and Healthcare sector, Cullinan Oncology's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Cullinan Oncology's Quick Ratio falls into.



Cullinan Oncology Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Cullinan Oncology's Quick Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Quick Ratio (A: Dec. 2019 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(100.091-0)/2.523
=39.67

Cullinan Oncology's Quick Ratio for the quarter that ended in Dec. 2019 is calculated as

Quick Ratio (Q: Dec. 2019 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(100.091-0)/2.523
=39.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cullinan Oncology  (NAS:CGEM) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Cullinan Oncology Quick Ratio Related Terms

Thank you for viewing the detailed overview of Cullinan Oncology's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cullinan Oncology Business Description

Cullinan Oncology logo
Industry
Healthcare » Biotechnology NAICS : 541713 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Cullinan Oncology Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)